TrialThe Lancet. Oncology2020

Ripretinib in patients with advanced gastrointestinal stromal tumours (INVICTUS): a double-blind, randomised, placebo-controlled, phase 3 trial.

Jean-Yves Blay et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.